Conmed (CNMD) PT Rises To $94 On Surgical Smoke Opportunity - Needham
Tweet Send to a Friend
Conmed (NASDAQ: CNMD)
Needham & Company analyst, Mike Matson, reiterated his Buy rating on shares of CONMED (NASDAQ: CNMD) and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham & Company analyst, Mike Matson, reiterated his Buy rating on shares of CONMED (NASDAQ: CNMD) and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
